WEBSITE BSE:0 NSE: Inc. Year: 2001 Industry: Fertilizers My Bucket: Add Stock
Last updated: 15:40
No Notes Added Yet
Agro Phos Ltd is in the manufacturing of fertilizers. The Company operates as a processor, supplier, marketer and exporter of various fertilizers. It manufactures fertilizers, which includes Single Super Phosphate (SSP), Nitrogen Phosphate and Potassium (NPK), Zinc Sulfate, Organic manure and Calcium Sulfate (commonly known as soil conditioner or gypsum). The Company additionally undertakes buying and selling of Diammonium Phosphate (DAP), Urea, Ammonium Sulfate and different fertilizers relying upon the demand of the purchaser. The Company sel...Read More
Agro Phos Ltd is in the manufacturing of fertilizers. The Company operates as a processor, supplier, marketer and exporter of various fertilizers. It manufactures fertilizers, which includes Single Super Phosphate (SSP), Nitrogen Phosphate and Potassium (NPK), Zinc Sulfate, Organic manure and Calcium Sulfate (commonly known as soil conditioner or gypsum). The Company additionally undertakes buying and selling of Diammonium Phosphate (DAP), Urea, Ammonium Sulfate and different fertilizers relying upon the demand of the purchaser. The Company sells SSP under the Brand call, Smriddhi; NPK underneath brand names, Smriddhi and Swaraj, and zinc sulfate and calcium sulfate beneath the brand name, Ratna. The Company operates over two manufacturing facilities located at 13 A/2, Industrial Area, A.B. Road, Dewas, (MP), and 135A-138A, Industrial Area, Meghnagar, Jhabua, Madhya Pradesh. It additionally operates an in-residence testing laboratory to test the goods as in keeping with satisfactory requirements. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹64 Cr.
Stock P/E 12.7
P/B 0.9
Current Price ₹31.6
Book Value ₹ 34.9
Face Value 10
52W High ₹47.6
Dividend Yield 0%
52W Low ₹ 23.9
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2022 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 34 | 11 | 3 | 24 | 0 | 23 | 30 | 40 | 40 | 36 |
| Other Income | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | -0 | 0 |
| Total Income | 34 | 11 | 3 | 27 | 0 | 23 | 30 | 40 | 40 | 36 |
| Total Expenditure | 31 | 25 | 7 | 26 | 0 | 19 | 26 | 32 | 36 | 33 |
| Operating Profit | 3 | -14 | -4 | 2 | 0 | 4 | 4 | 8 | 4 | 3 |
| Interest | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | -15 | -6 | 0 | 0 | 3 | 3 | 6 | 2 | 1 |
| Provision for Tax | 1 | -0 | -2 | 0 | 0 | 0 | 0 | 2 | 0 | 1 |
| Profit After Tax | 1 | -15 | -4 | -0 | 0 | 2 | 3 | 4 | 2 | 1 |
| Adjustments | -0 | -0 | -0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | -15 | -4 | -0 | 0 | 2 | 2 | 4 | 2 | 1 |
| Adjusted Earnings Per Share | 0.7 | -7.2 | -2.1 | -0.1 | 0 | 1.2 | 1.2 | 2.2 | 1 | 0.5 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|
| Net Sales | 107 | 120 | 146 |
| Other Income | 1 | 1 | 0 |
| Total Income | 108 | 121 | 146 |
| Total Expenditure | 110 | 106 | 127 |
| Operating Profit | -2 | 15 | 19 |
| Interest | 3 | 4 | 4 |
| Depreciation | 2 | 2 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 |
| Profit Before Tax | -7 | 9 | 12 |
| Provision for Tax | -2 | 4 | 3 |
| Profit After Tax | -5 | 5 | 10 |
| Adjustments | 0 | 0 | 0 |
| Profit After Adjustments | -5 | 5 | 9 |
| Adjusted Earnings Per Share | -2.6 | 2.5 | 4.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 12% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 5% | -6% | 22% | NA% |
| ROE Average | 9% | -1% | -1% | -1% |
| ROCE Average | 15% | 5% | 5% | 5% |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Shareholder's Funds | 48 | 65 |
| Minority's Interest | 0 | 0 |
| Borrowings | 1 | 1 |
| Other Non-Current Liabilities | 1 | 3 |
| Total Current Liabilities | 48 | 89 |
| Total Liabilities | 99 | 158 |
| Fixed Assets | 24 | 23 |
| Other Non-Current Assets | 6 | 7 |
| Total Current Assets | 68 | 129 |
| Total Assets | 99 | 158 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 |
| Cash Flow from Operating Activities | 3 | 3 |
| Cash Flow from Investing Activities | -2 | 0 |
| Cash Flow from Financing Activities | -1 | -4 |
| Net Cash Inflow / Outflow | -0 | 0 |
| Closing Cash & Cash Equivalent | 0 | 0 |
| # | Mar 2024 | Mar 2025 |
|---|---|---|
| Earnings Per Share (Rs) | -2.6 | 2.48 |
| CEPS(Rs) | -1.75 | 3.45 |
| DPS(Rs) | 0 | 0 |
| Book NAV/Share(Rs) | 23.8 | 32.24 |
| Core EBITDA Margin(%) | -2.48 | 11.65 |
| EBIT Margin(%) | -3.54 | 10.6 |
| Pre Tax Margin(%) | -6.72 | 7.41 |
| PAT Margin (%) | -4.93 | 4.2 |
| Cash Profit Margin (%) | -3.31 | 5.83 |
| ROA(%) | -5.35 | 3.93 |
| ROE(%) | -10.94 | 8.87 |
| ROCE(%) | -4.93 | 14.91 |
| Receivable days | 43.02 | 53.19 |
| Inventory Days | 115.73 | 139.02 |
| Payable days | 76.58 | 155.01 |
| PER(x) | 0 | 11.52 |
| Price/Book(x) | 1.52 | 0.89 |
| Dividend Yield(%) | 0 | 0 |
| EV/Net Sales(x) | 0.95 | 0.71 |
| EV/Core EBITDA(x) | -49.8 | 5.72 |
| Net Sales Growth(%) | 0 | 11.89 |
| EBIT Growth(%) | 0 | 435.24 |
| PAT Growth(%) | 0 | 195.43 |
| EPS Growth(%) | 0 | 195.43 |
| Debt/Equity(x) | 0.6 | 0.43 |
| Current Ratio(x) | 1.4 | 1.44 |
| Quick Ratio(x) | 0.7 | 0.86 |
| Interest Cover(x) | -1.11 | 3.32 |
| Total Debt/Mcap(x) | 0.39 | 0.49 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 54.27 | 54.27 | 54.27 | 54.27 | 54.27 | 54.27 | 54.27 | 54.27 | 54.27 | 54.27 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 45.73 | 45.73 | 45.73 | 45.73 | 45.73 | 45.73 | 45.73 | 45.73 | 45.73 | 45.73 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 | 0.93 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 | 2.03 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
